Compounds > 5,8,11-eicosatriynoic acid
Page last updated: 2024-10-21

5,8,11-eicosatriynoic acid and Plasma Cell Tumor

5,8,11-eicosatriynoic acid has been researched along with Plasma Cell Tumor in 1 studies

5,8,11-eicosatriynoic acid: a lipoxygenase inhibitor
5,8,11-icosatriynoic acid : A C20 polyunsaturated fatty acid having three triple bonds in the 5-, 8- and 11-positions.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Orning, L1
Hammarström, S1

Other Studies

1 other study available for 5,8,11-eicosatriynoic acid and Plasma Cell Tumor

ArticleYear
Inhibition of leukotriene C and leukotriene D biosynthesis.
    The Journal of biological chemistry, 1980, Sep-10, Volume: 255, Issue:17

    Topics: Animals; Arachidonic Acids; Biological Assay; Borates; Cell Line; Dose-Response Relationship, Drug;

1980